Surveillance of antibiotic resistance in clinical isolates of streptococcus pneumoniae collected in Belgium during winter 2000-2001

被引:0
|
作者
Vanhoof, R
Carpentier, M
Cartuyvels, R
Damée, S
Fagnart, O
Garrino, MG
Glupczynski, Y
Gordts, B
Govaerts, D
Magerman, K
Mans, I
Surmont, I
Van Bossuyt, E
Van De Vyvere, M
Van Landuyt, H
Van Nimmen, L
Van Noyen, R
机构
[1] Pasteurinst Brussel, Eenheid Antibiot Onderzoek, B-1180 Brussels, Belgium
[2] Hop Citadelle, Microbiol Lab, B-4000 Liege, Belgium
[3] Clin St Etienne, Lab Van Den Abbeele, B-1210 Brussels, Belgium
[4] Clin Univ Mt Godinne, Microbiol Lab, B-5530 Yvoir, Belgium
[5] ZA St Jan, Microbiol Lab, B-8000 Brugge, Belgium
[6] CHU Andre Vesale, Microbiol Lab, B-6110 Montignies Le Tilleul, Belgium
[7] Virga Jesseziekenhuis, Microbiol Lab, B-3500 Hasselt, Belgium
[8] H Hartziekenhuis, Microbiol Lab, B-8800 Roeselare, Belgium
[9] AZ Stuivenberg, Microbiol Lab, B-2060 Antwerp, Belgium
[10] AZ Jan Palfijn, Microbiol Lab, B-9000 Ghent, Belgium
[11] Imeldaziekenhuis, Microbiol Lab, B-2820 Bonheiden, Belgium
来源
ACTA CLINICA BELGICA | 2003年 / 58卷 / 02期
关键词
S; pneumoniae; resistance; surveillance;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A total of 314 isolates of Streptococcus pneumoniae collected by 10 different laboratories were tested for their susceptibility by using a microdilution technique following NCCLS recommendations. The following antibiotics were included: penicillin, ampicillin, amoxicillin, amoxicillin/clavulanate, cefaclor, cefuroxime, cefotaxime, imipenem, ciprofloxacin, gemifloxacin, levofloxacin, erythromycin, clarithromycin, azithromycin, miocamycin, clindamycin and tetracycline. The insusceptibility rate (IR) to penicillin was 21.0% [10.8% intermediate (greater than or equal to0.12-1 mug/mL) and 10.2 % high-level (greater than or equal to2 mug/mL)], to cefotaxime 7.3 % [3.5 % intermediate (greater than or equal to 1 mug/mL) and 3.8 % high-level (greater than or equal to2 mug/mL)], to imipenem 3.8 % [3.8 % intermediate (greater than or equal to0.25-0.5 mug/mL) and 0 % high-level (greater than or equal to1 mug/mL)], to ciprofloxacin 11.2 % [8.3 % intermediate (2 mug/mL) and 3.9 % high-level (greater than or equal to4 mug/mL)], to erythromycin 30.3 % [3.5 % intermediate (0.5 mug/mL) and 26.8 % high-level (greater than or equal to1 mug/mL)] and to tetracycline 38.5 % [0.9 % intermediate (4 mug/mL) and 37.6 % high-level (greater than or equal to8 mug/mL)]. No decreased susceptibility was found for gemifloxacin (greater than or equal to0.5 mug/mL). This compound was the most active with MIC50, MIC90 and an IR of 0.015 mug/mL, 0.03 mug/mL, and 0 % respectively, followed by amoxicillin/ clavulanate, amoxicillin and imipenem (MIC50, MIC90 and IR: 0.015 mug/mL, 1 mug/mL, 1.6 %/ 0.015 mug/mL, 1 mug/mL, 1.9 %/ 0.008 mug/mL, 0.12 mug/mL, 3.8 % respectively). Compared to the 1999 surveillance, penicillin and tetracycline-insusceptibility increased with 4.9 % and 15.6% respectively, while cefotaxime, erythromycin and ciprofloxacin insusceptibility decreased with 5.4 %, 5.8 % and 4.4 % respectively. MICs of all beta-lactams rose with those of penicillin for penicillin-insusceptible isolates. Imipenem, cefotaxime, amoxicillin and amoxicillin/clavulanate were generally 4, 2, 1 and 1 doubling dilutions respectively more potent than penicillin on these isolates while ampicillin, cefuroxime and cefaclor were generally 1, 2 and 4 dilutions respectively less potent. Most penicillin-insusceptible isolates remained fully susceptible to amoxicillin/clavulanate (92.4 %), amoxicillin (90.9 %) and imipenem (81.8 %). Erythromycin-tetracycline insusceptibility was the most common resistance phenotype (14.3 %). Three- and four-fold resistance was found in 12.4 % and 1.6 % respectively of the isolates. Most penicillin-insusceptible isolates were of capsular types 14 (22.7 %), 23 (21.2 %), 6 (18.2 %), 9 (13.6 %) and 19 (12.1 %).
引用
收藏
页码:111 / 119
页数:9
相关论文
共 50 条
  • [1] Survey of antibiotic resistance in non-invasive clinical isolates of Streptococcus pneumoniae collected in Belgium during winter 2006
    Vanhoof, R.
    Van Eldere, J.
    Verhaegen, J.
    ACTA CLINICA BELGICA, 2007, 62 (06): : 448 - 448
  • [2] Surveillance of antibiotic resistance in non invasive clinical isolates of streptococcus pneumoniae collected in belgium during winters 2003 and 2004.
    Vanhoof, R.
    Carpentier, M.
    Cartuyvels, R.
    Damée, S.
    Fagnart, O.
    Frans, J.
    Gordts, B.
    Glupczynski, Y.
    Goffinet, P.
    Govaerts, D.
    Lefèvre, Ph.
    Lontie, M.
    Magerman, K.
    Mans, I.
    Meunier, F.
    Moonens, F.
    Surmont, I.
    Van Bossuyt, E.
    Van De Vyvere, M.
    Van Eldere, J.
    Van Landuyt, H.
    Van Nimmen, L.
    Van Noyen, R.
    Verhaegen, J.
    ACTA CLINICA BELGICA, 2006, 61 (02): : 49 - 57
  • [3] Prevalence and molecular analysis of macrolide and fluoroquinolone resistance among isolates of Streptococcus pneumoniae collected during the 2000-2001 PROTEKT US study
    Brown, SD
    Farrell, DJ
    Morrissey, I
    JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (11) : 4980 - 4987
  • [4] Increase of resistance to macrolides in invasive Streptococcus pneumoniae in Spain (2000-2001)
    Oteo, J
    Campos, J
    Cruchaga, S
    Baquero, G
    Lázaro, E
    Madurga, M
    de Abajo, FJ
    Baquero, F
    CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (09) : 851 - 854
  • [5] 10th Survey of antimicrobial resistance in noninvasive clinical isolates of Streptococcus pneumoniae collected in Belgium during winter 2007-2008
    Vanhoof, R.
    Camps, K.
    Carpentier, M.
    De Craeye, S.
    Frans, J.
    Glupczynski, Y.
    Goffinet, P.
    Gordts, B.
    Govaerts, D.
    Ide, L.
    Lefevre, P.
    Lontie, M.
    Cartuyvels, R.
    Meunier, F.
    Mulongo, B.
    Philippart, I.
    Surmont, I.
    Van Bossuyt, E.
    Van Eldere, J.
    Verhaegen, J.
    PATHOLOGIE BIOLOGIE, 2010, 58 (02): : 147 - 151
  • [6] Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in Canada during 2000
    Low, DE
    de Azavedo, J
    Weiss, K
    Mazzulli, T
    Kuhn, M
    Church, D
    Forward, K
    Zhanel, G
    Simor, A
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (05) : 1295 - 1301
  • [7] High prevalence of the ermB gene among erythromycin-resistant Streptococcus pneumoniae isolates in German during the winter of 2000-2001 and in vitro activity of telithromycin
    Kresken, M
    Henrichfreise, B
    Bagel, S
    Brauers, J
    Wiedemann, B
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (08) : 3193 - 3195
  • [8] Macrolide-resistant Streptococcus pneumoniae and Streptococcus pyogenes in the pediatric population in Germany during 2000-2001
    Reinert, RR
    Lütticken, R
    Bryskier, A
    Al-Lahham, A
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (02) : 489 - 493
  • [9] Clonal relationships of Streptococcus pneumoniae isolates harbouring multiple antibiotic resistance from Belgium
    O'Hara, F. P.
    Van Eldere, J.
    Mera, R.
    Miller, L.
    Poupard, J.
    Amrine-Madsen, H.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S266 - S267
  • [10] ANTIBIOTIC-RESISTANCE OF CLINICAL ISOLATES OF STREPTOCOCCUS-PNEUMONIAE IN GREECE
    KANAVAKI, S
    KARABELA, S
    MARINIS, E
    LEGAKIS, NJ
    JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (12) : 3056 - 3058